Streetbeat News

BLCM

Bellicum Pharmaceuticals Inc

www.bellicum.com

CEO

Richard Fair

Employees

Industry

Pharmaceutical Preparation Manufacturing

Bellicum is a clinical stage biopharmaceutical company striving to deliver cures through controllable cell therapies. The company's next-generation product candidates are differentiated by powerful cell signaling technologies designed to produce more effective CAR-T cell therapies. Bellicum's GoCAR-T® product candidates, BPX-601 and BPX-603, are designed to be more efficacious CAR-T cell products capable of overriding key immune inhibitory mechanisms.

Open

N/A

Mkt cap

N/A

Volume

N/A

High

N/A

P/E Ratio

N/A

52-wk high

N/A

Low

N/A

Div yield

N/A

52-wk low

N/A

During Friday's intraday session, several health care stocks experienced significant price movements. Minerva Surgical (UTRS) shares increased by 111.8%, while Bellicum Pharmaceuticals (BLCM) shares declined by 63.7%.

Portfolio Pulse from Benzinga Insights

June 02, 2023 | 5:31 pm

Capri Holdings shares dropped 10.8% following Q4 results, with the company projecting lower-than-expected Q1 revenue and EPS. Other stocks experienced significant price movements during Wednesday's mid-day session, with gainers including Aridis Pharmaceuticals, Bluejay Diagnostics, and VIQ Solutions, while losers included QualTek Services, Belite Bio, and Advance Auto Parts.

Portfolio Pulse from Lisa Levin

May 31, 2023 | 5:04 pm

12 health care stocks experienced significant price movements during Wednesday's pre-market session, with 6 gainers and 6 losers. Notable gainers include Aridis Pharmaceuticals, VistaGen Therapeutics, and Marker Therapeutics, while notable losers include Belite Bio, Biodexa Pharmaceuticals, and Bellicum Pharmaceuticals.

Portfolio Pulse from Benzinga Insights

May 31, 2023 | 1:08 pm

LL Flooring shares gained 19.1% in pre-market trading after receiving a $5.76 per share unsolicited, non-binding proposal from Cabinets To Go, a subsidiary of F9 Brands. Other stocks with significant pre-market movements include VIQ Solutions, Appreciate Holdings, VistaGen Therapeutics, and WANG & LEE GROUP.

Portfolio Pulse from Lisa Levin

May 31, 2023 | 12:40 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.